Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy

Published:2024-09-12 Issue:1 Volume:13 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Vijayan Vishnu Vijay¹,Nair Preethi Gopalakrishnan¹²,Gujar Shashi¹²³⁴⁵^ORCID

Affiliation:

1. Department of Pathology, Dalhousie University, Halifax, Canada

2. Beatrice Hunter Cancer Research Institute, Halifax, Canada

3. Department of Cell Biology, Harvard Medical School, Harvard University, Boston, MA, USA

4. Department of Microbiology & Immunology, Dalhousie University, Halifax, Canada

5. Department of Biology, Dalhousie University, Halifax, Canada

Funder

Canadian Institutes of Health Research

Beatrice Hunter Cancer Research Institute

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2024.2400429

Reference7 articles.

1. Metabolic programs tailor T cell immunity in viral infection, cancer, and aging

2. Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma

3. CD38–RyR2 axis–mediated signaling impedes CD8 ⁺ T cell response to anti-PD1 therapy in cancer

4. Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer

5. NAD-Induced T Cell Death

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP